Compute Health Acquisition shareholders are scheduled to vote July 28 on a proposed merger with Allurion Technologies.
Allurion offers a weight-loss platform to help individuals overcome obesity.
As announced in February, the deal has an implied $500 million valuation.
The proposed transaction includes a fully committed PIPE led by RTW Investments and a non-dilutive, synthetic royalty financing from RTW Investments that will close concurrently with the business combination.
The SPAC raised $750 million in a February 2021 IPO, but took a hit last December when redemptions reached 71% ahead of an extension vote.
